They found that TH-MYCN/Gal-1−/− double transgenic mice displayed impaired tumor angiogenesis, splenomegaly, and impaired T cell tumor-infiltration, with no differences in T cell activation or apoptosis rate [72]. This evidence concerns the gene MYCN and neoplasm.